HIGHLIGHTS
- who: Peizhang Li from the NanoBio Diagnostics, United States Uniformed Services University of the have published the research: MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression, in the Journal: (JOURNAL)
- what: The authors investigated the expression of MAFG-AS1 in prostate cancer according to the TCGA database and a tissue microarray, and determined its role as a prognostic biomarker in prostate cancer.
- how: The results showed that these genes were enriched in ribosome biogenesis ribonucleoprotein complex subunit organization Since functional enrichment analysis revealed that MAFG-AS1 may be involved in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.